Nanoparticle drug aims to wake up immune system against tumors
Disease control
Recruiting now
This study tests a new drug called UI-102, which is a tiny nanoparticle designed to activate the immune system to fight cancer. It is for people with advanced solid tumors that have not responded to standard treatments. The trial will enroll 140 participants to first find the saf…
Phase: PHASE1, PHASE2 • Sponsor: United Immunity, co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC